Engineered Cell Line for Rapid Neutralizing Antibody Quantification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for quantifying neutralizing antibodies (NAbs) are imprecise, labor-intensive, and require specialized personnel and facilities, often taking several days to complete, making them inefficient for precise and rapid analysis.
Innovation Solution
A cell-based assay using a mammalian cell line engineered to express and secrete a ligand of interest and a reporter gene from a shared inducible promoter, allowing for the quantification of ligand expression and activity, with a second reporter gene controlled by a chimeric promoter for ligand-responsive activity, enabling rapid detection of NAbs without the need for serial dilutions or external ligand addition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional methods are used for quantifying neutralizing antibodies, then the assay can be performed with standard procedures, but the process is labor-intensive, time-consuming (several days), and requires specialized personnel and facilities
Solution Approach 1:
The cell line autonomously produces the ligand of interest through integrated genomic DNA, eliminating the need for external ligand addition or serial dilutions. The cell's own metabolic machinery serves the assay function, allowing rapid processing without specialized personnel for ligand preparation and handling.
Solution Approach 2:
The assay combines multiple functions into a single cell system: the cell produces the ligand, expresses the receptor, and generates the reporter signal all within one integrated system. This merging eliminates separate steps for ligand preparation, cell treatment, and signal detection that characterize conventional methods.
2Measurement precision
If conventional assay procedures are used, then standard protocols can be followed, but the precision and selectivity in determining neutralizing titers are reduced
Solution Approach 1:
The reporter gene expression provides direct feedback on ligand-receptor interaction status. When neutralizing antibodies are present, they block ligand binding to the receptor, which immediately reduces reporter gene expression. This feedback mechanism enables precise quantification of NAb levels through measurable changes in reporter signal intensity.
Solution Approach 2:
The assay replaces complex mechanical procedures (serial dilutions, manual ligand addition, multiple handling steps) with a biological system where the cell's own machinery performs these functions. The genomic integration of the ligand production pathway eliminates the need for external manipulation, substituting mechanical complexity with biological autonomy.
3Reliability
If labor-intensive procedures are used, then thorough analysis can be performed, but resource requirements and operational burden increase
Solution Approach 1:
The cell line autonomously maintains the ligand production capability through integrated genomic DNA, eliminating the need for continuous external supply chains, storage facilities, and preparation resources. The system serves itself by producing its own ligand indefinitely, reducing resource requirements while maintaining analysis reliability.
Solution Approach 2:
The assay changes the fundamental parameter of ligand delivery from external addition to endogenous production. This parameter change transforms the assay from a resource-intensive procedure requiring continuous external input to a self-sustaining system that maintains reliability through internal production mechanisms.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for precise and rapid quantification of NAbs within hours, reducing labor and resource requirements, and providing a high degree of precision and selectivity in determining neutralizing titers, suitable for high-throughput analysis and applicable to various biopharmaceuticals.
Implementation Method 1
Cell surface proteins permit intracellular transduction of extracellular signals. Cell surface proteins provide eukaryotic, as well as prokaryotic, cells a means to detect extracellular signals and transduce such signals intracellularly in a manner that ultimately results in a cellular response
Implementation Method 2
a first DNA construct having a sequence that includes a first set of one or more transcription control elements, which is inducible by the ligand, and also encodes a first measurable tag (first reporter gene product), whose expression is driven by the first set of one or more transcription control elements when induced by the presence of the ligand
Data Source
AI summary
The present invention provides a cell for use in a one-step cell-based assay for an extracellular ligand (e.g., IFNα) that initiates a ligand-specific signal at the nucleus of the cell and for neutralizing antibodies against the extracellular ligand. The cell-based one-step assay allows both the extracellular ligand concentration and the neutralizing antibody titer to be quantified in a single sample (e.g., serum) without the need for sample dilution and addition of exogenous extracellular ligand.